Psoriatic Disease and MASLD: What Is the Connection?

Hello. I'm Dr Danielle Brandman. I'm the medical director of liver transplantation at NewYork-Presbyterian | Weill Cornell Medicine in New York City. Today I'll be discussing fatty liver, which we now call metabolic dysfunction–associated steatotic liver disease, or MASLD. I'll focus on how this disease may affect people with psoriatic disease.

MASLD is really quite common; it affects about 30% of the entire world's population. What is MASLD? MASLD is defined as having fat or steatosis in the liver, in combination with at least one cardiometabolic risk factor, such as overweight or obesity (particularly if the weight is concentrated in the midsection), diabetes or insulin resistance, elevated cholesterol, and/or elevated blood pressure.

This disease is often identified when you're having routine blood work and elevated liver enzymes are identified, or when some sort of abdominal imaging study, such as an ultrasound, CT scan, or MRI, is being done to evaluate symptoms like abdominal pain. 

See the originl article and the video here.